Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.81	6.21	20.75	44.58	69.72
Short-Term Investments	11.94	34.57	54.31	45.6	37.08
Cash & Short-Term Investments	17.75	40.78	75.06	90.18	106.8
Cash Growth	-56.47%	-45.66%	-16.77%	-15.56%	-20.19%
Other Current Assets	5.14	3.25	2.38	3.57	4.87
Total Current Assets	22.9	44.04	77.44	93.75	111.67
Net Property, Plant & Equipment	1.05	0.81	0.62	0.68	1.43
Other Intangible Assets	67.82	60.05	63.67	5.9	-
Goodwill	-	-	17.63	-	-
Long-Term Investments	-	-	-	3.58	19.93
Other Long-Term Assets	1.76	9.58	8.54	-	0.19
Total Assets	93.52	114.48	167.9	103.91	133.23
Accounts Payable	2.22	2.9	2.03	0.57	4.91
Accrued Expenses	10.61	4.38	3.44	2.5	9.31
Current Portion of Long-Term Debt	18.03	-	-	-	-
Other Current Liabilities	12.37	-	4.1	-	-
Total Current Liabilities	43.23	7.28	9.57	3.07	14.22
Long-Term Debt	-	14.32	13.43	-	-
Long-Term Leases	0.33	0.39	0.32	-	0.42
Other Long-Term Liabilities	85.68	62.34	59.49	0.25	-
Total Long-Term Liabilities	86.01	77.05	73.24	0.25	0.42
Total Liabilities	129.24	84.33	82.82	3.32	14.64
Common Stock	0.06	0.04	0.04	0.04	0.03
Additional Paid-in Capital	418.93	406.61	401.64	389.11	355.23
Accumulated Other Comprehensive Income	5.75	-0.04	3.05	-0.29	-0.08
Retained Earnings	-460.45	-376.47	-319.64	-288.26	-236.6
Shareholders' Equity	-35.71	30.15	85.08	100.59	118.59
Total Liabilities & Equity	93.52	114.48	167.9	103.91	133.23
Total Debt	18.36	14.72	13.75	0	0.42
Net Cash (Debt)	-0.6	26.07	61.31	90.18	106.38
Net Cash Growth	-	-57.48%	-32.02%	-15.23%	-20.38%
Net Cash Per Share	-0.12	6.03	16.46	26.92	35.80
Book Value	-35.71	30.15	85.08	100.59	118.59
Book Value Per Share	-7.13	6.97	22.85	30.03	39.90
Tangible Book Value	-103.53	-29.9	3.79	94.69	118.59
Tangible Book Value Per Share	-20.67	-6.91	1.02	28.27	39.90

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q